650 Chaperone J-domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Lipids and lipid-like molecules | 2 | 0.6 | 3.64× | not tested | |
| Organoheterocyclic compounds | 1 | 0.8 | 1.32× | not tested | |
| Homogeneous non-metal compounds | 1 | 1.1 | 0.94× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 1.4 | 0.73× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04557 | ACD | Arachidonic Acid | 12 |
| DB03796 | PLM | Palmitic Acid | 2 |
| DB00171 | ATP | ATP | 1 |
| DB12010 | — | Fostamatinib | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ACD | ARACHIDONIC ACID | 9 |
| 1PS | 3-PYRIDINIUM-1-YLPROPANE-1-SULFONATE | 1 |
| CL | CHLORIDE ION | 1 |
| PLM | PALMITIC ACID | 1 |